UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2044 - 2053
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Factor IX - analysis | Antibodies, Bispecific - pharmacology | Hemophilia A - immunology | Humans | Middle Aged | Male | Hemorrhage - prevention & control | Injections, Subcutaneous - adverse effects | Hemophilia A - complications | Dose-Response Relationship, Drug | Antibodies, Bispecific - therapeutic use | Factor X - analysis | Antibodies, Monoclonal, Humanized - blood | Antibodies, Monoclonal, Humanized - pharmacology | Hemorrhage - etiology | Adolescent | Factor VIII - antagonists & inhibitors | Adult | Antibodies, Bispecific - blood | Drug Therapy, Combination | Hemophilia A - drug therapy | Child | Factor VIII - therapeutic use | Immunoglobulins | Inhibitor drugs | Intravenous administration | Body weight | Hemorrhage | Patients | Bleeding | Clotting | Mimicry | Thromboplastin | Coagulation factors | Hemophilia | Alloantibodies | Children | Drug therapy | Bispecific antibodies | Index Medicus | Abridged Index Medicus
Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 2005, Volume 333, Issue 2, pp. 328 - 335
Monoclonal antibodies | Angiogenesis | Tumor | Chemotherapy | VEGF | Endothelium | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Humans | Neoplasms - blood supply | Treatment Outcome | Vascular Endothelial Growth Factor A - immunology | Clinical Trials as Topic | Vascular Endothelial Growth Factor A - metabolism | Antineoplastic Agents - administration & dosage | Bevacizumab | Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Animals | Antibodies, Monoclonal - administration & dosage | Neoplasms - immunology | Neovascularization, Pathologic - prevention & control | Neovascularization, Pathologic - immunology | Neovascularization, Pathologic - metabolism | Tyrosine | Diabetic retinopathy | Metastasis | Biopharmaceutics | Macular degeneration | Neovascularization | Ophthalmology | Angiogenesis inhibitors | Health aspects | Vascular endothelial growth factor | Cancer | Index Medicus
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 02/2018, Volume 16, Issue 2, pp. 367 - 377
platelet | thrombosis | ERp72 | platelet aggregation | redox | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Blood Platelets - immunology | Humans | Male | Protein Disulfide-Isomerases - antagonists & inhibitors | Blood Platelets - enzymology | Protein Disulfide-Isomerases - immunology | Calcium - blood | Membrane Glycoproteins - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - pharmacology | Platelet Glycoprotein GPIIb-IIIa Complex - metabolism | Platelet Aggregation Inhibitors - pharmacology | Platelet Aggregation - drug effects | Membrane Glycoproteins - immunology | Thrombosis - blood | Thrombosis - prevention & control | Blood Platelets - drug effects | Disease Models, Animal | Mice, Inbred C57BL | Thrombosis - enzymology | Membrane Glycoproteins - blood | Platelet Adhesiveness - drug effects | Fibrinolytic Agents - pharmacology | Protein Disulfide-Isomerases - blood | Animals | Signal Transduction - drug effects | Fibrinogen - metabolism | Platelet Activation - drug effects | Enzymes | Thiols | Monoclonal antibodies | Plants | Thrombosis | Blood clot | Protein binding | Disulfide bonds | Calcium mobilization | Protein folding | Secretion | Rodents | Platelet aggregation | Endoplasmic reticulum | Cell surface | Index Medicus | In Focus | PLATELETS
Journal Article
Movement disorders, ISSN 0885-3185, 02/2017, Volume 32, Issue 2, pp. 211 - 218
clinical trial | synucleinopathy | Parkinson's disease | protein aggregation | protein misfolding | Antibodies, Monoclonal, Humanized - adverse effects | alpha-Synuclein - blood | Double-Blind Method | Humans | Middle Aged | alpha-Synuclein - immunology | Male | Healthy Volunteers | alpha-Synuclein - drug effects | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Immunoglobulin G - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Adult | Female | Infusions, Intravenous | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2013, Volume 57, Issue 12, pp. 6147 - 6153
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Injections, Intravenous | Antiviral Agents - pharmacokinetics | Double-Blind Method | Antiviral Agents - blood | Humans | Drugs, Investigational - pharmacokinetics | Half-Life | Immunoglobulin Fc Fragments - chemistry | Male | Metabolic Clearance Rate | Antibodies, Monoclonal, Humanized - pharmacokinetics | Antibodies, Monoclonal, Humanized - blood | Adult | Female | Index Medicus | Pharmacology
Journal Article
Gut, ISSN 0017-5749, 08/2006, Volume 55, Issue 8, pp. 1131 - 1137
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Double-Blind Method | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Crohn Disease - immunology | Antibodies, Monoclonal - blood | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | C-Reactive Protein - metabolism | Crohn Disease - blood | Crohn Disease - drug therapy | Interferon-gamma - immunology | Gastrointestinal Agents - therapeutic use | Interferon-gamma - antagonists & inhibitors | Adult | Female | Aged | Gastrointestinal Agents - adverse effects | Gastrointestinal Agents - blood | Index Medicus | Abridged Index Medicus | Crohn's disease | Inflammatory Bowel Disease | monoclonal antibody | fontolizumab | immunogenicity | interferon γ
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 03/2020, Volume 145, Issue 3, pp. 907 - 921.e3
mouse | Anaphylaxis | antibody | IgE | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Allergens | Medical research | Antigens | Intravenous administration | Cytokines | Cloning | Immunoglobulin E | Allergies | Eggs | Chromatography | Proteins | Interleukin 4 | Cord blood | Lymphocytes | Monoclonal antibodies | Mast cells | Ascites | Drug dosages | Peritoneum | Index Medicus | Abridged Index Medicus
Journal Article
Gut, ISSN 0017-5749, 11/2006, Volume 55, Issue 11, pp. 1568 - 1574
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Immunomodulators | Other diseases. Semiology | Immunoglobulin G - blood | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Colitis, Ulcerative - immunology | Antibodies, Monoclonal - blood | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Immunosuppressive Agents - blood | Adult | Female | Colitis, Ulcerative - drug therapy | Child | Immunosuppressive Agents - administration & dosage | Severity of Illness Index | Double-Blind Method | Drug Administration Schedule | Receptors, Interleukin-2 - blood | Immunoglobulin G - therapeutic use | Treatment Outcome | Immunoglobulin G - administration & dosage | Receptors, Interleukin-2 - immunology | Immunoglobulin G - adverse effects | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Adolescent | Lymphocyte Count | Immunosuppressive Agents - adverse effects | T-Lymphocytes - immunology | Pharmaceutical research | Reports | Care and treatment | Ulcerative colitis | Proteins | Inflammatory bowel disease | Immunoglobulins | Cytokines | Lymphocytes | Chicken pox | Infections | Pharmacists | Viral infections | Manuscripts | Asthma | Index Medicus | Abridged Index Medicus | medical treatment | ulcerative colitis | Inflammatory Bowel Disease | controlled trials | CD‐25 | daclizumab
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 711 - 721
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | General aspects | Medical sciences | Other diseases. Semiology | Antibodies, Monoclonal, Humanized - adverse effects | Glucocorticoids - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Integrins - immunology | Middle Aged | Induction Chemotherapy | Male | Crohn Disease - drug therapy | Infusions, Intravenous - adverse effects | Adult | Antibodies - blood | Female | Maintenance Chemotherapy | Antibodies, Monoclonal, Humanized - immunology | Drug Therapy, Combination | Integrins - antagonists & inhibitors | Monoclonal antibodies | Crohn's disease | Research | Drug therapy | Inflammatory bowel disease | Headache | Medical research | Pain | Intravenous administration | Ulcers | Clinical trials | Remission | Rhinopharyngitis | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article